Post-approval studies (Phase 4)Study completedNCT04535037
What this trial is testing
Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
Who this might be right for
Diphtheria
GlaxoSmithKline 500